Psychiatry & Neurology Doctors in Indio, CA Accepting Medicare

13 Psychiatry & Neurology doctors found. Showing 1 - 13

Dr. Jessee Klein Valentine, D.O. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8455

Phill Victor Halamandaris, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 47825 Oasis St, Indio Mental Health Clinic, Indio, CA 92201 Phone: 760-863-8455    Fax: 760-863-8587

Dr. Richard Duboe Seigle, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St., Indio, CA 92201 Phone: 760-863-8455    Fax: 760-863-8587

Michael John Brase, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8455

Dr. Harry David Goldwasser, MD Psychiatry & Neurology - Addiction Psychiatry Medicare: Medicare Enrolled Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-416-7951    Fax: 760-864-8587

Elton Parker-calderon, RADT-1 Psychiatry & Neurology - Addiction Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-563-8632    Fax: 760-863-8631

Ronald Marcus, Psychiatry & Neurology - Addiction Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 81880 Doctor Carreon Blvd, Suite 301, Indio, CA 92201 Phone: 760-989-4900

Dr. Michael Farell Massa, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 47825 Oasis St, Riverside County Dept. Of Mental Health, Indio, CA 92201 Phone: 760-863-8507

Dr. Chun Che Lai, M.D,. M.H.A Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8550

David Suchowiecky, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8455

Elmo Shin Lee, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 82485 Miles Ave, Indio, CA 92201 Phone: 760-347-4347    Fax: 760-342-7829

Seamus Lucien Connolly, DO Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 81880 Dr Carreon Blvd Ste B207, Indio, CA 92201 Phone: 442-324-0014    Fax: 442-324-0016

Dr. Marcia Dean Hudson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8455

News Archive

DNA gyrase B could rapidly eliminate TB, shorten treatment time

In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections.

WHI study shows no significant link between vitamin D levels and menopause symptoms

A new study from the Women's Health Initiative shows no significant connection between vitamin D levels and menopause symptoms. The study was published online today in Menopause, the journal of The North American Menopause Society.

Improving synchronization of brain waves enhances learning and self-control

Robert Reinhart calls the medial frontal cortex the "alarm bell of the brain." "If you make an error, this brain area fires," says Reinhart, an assistant professor of psychological and brain sciences at Boston University. "If I tell you that you make an error, it also fires.

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

Read more Medical News

› Verified 5 days ago